Combs Andrew
CIK 0001825005
EVP, Head of Chemistry
Filings
8
Latest Feb 5, 2026
Issuers covered
1
Showing
8 of 8
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | +4.1% | -5.6% | +24.0% | -6.2% |
| 90 days | 3 | 33% | -21.5% | -41.9% | +20.9% | -43.3% |
| 180 days | 3 | 33% | -6.9% | -32.3% | +45.3% | -33.8% |
| 365 days | 3 | 100% | +173.2% | +76.6% | +369.1% | +73.8% |
Issuers
Companies where Combs Andrew has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 8 | Feb 5, 2026 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|